Mm. Elbaseir et Iw. Kellaway, POLY(L-LACTIC ACID) MICROSPHERES FOR PULMONARY DRUG-DELIVERY - RELEASE KINETICS AND AEROSOLIZATION STUDIES, International journal of pharmaceutics, 175(2), 1998, pp. 135-145
We have previously developed poly(L-lactic acid) (PLA) microspheres co
ntaining nedocromil sodium and beclomethasone dipropionate (BDP) for a
erosolisation to the respiratory tract (El-Baseir, M.M., Phipps, M.A.,
Kellaway, I.W., Preparation and subsequent degradation of poly(L-lact
ic acid) microspheres suitable for aerosolisation: a physico-chemical
study. Int. J. Pharm. 151 (1997) 145-153). In this study we have inves
tigated the in vitro release kinetics of these two drugs from PLA micr
ospheres and the deposition of the microspheres in an in vitro lung mo
del (Andersen cascade impactor) following aerosolisation from a dry po
wder inhaler (Spinhaler(R)). The in vitro kinetics of drug release rev
ealed a controlled release of nedocromil sodium over 8 days with a bur
st effect (27-60%, w/w) which varied with the particle size of the mic
rospheres. For BDP entrapped in PLA microspheres, controlled release o
f BDP occurred over 6 days. BDP release was determined by measuring th
e shift in the phase transition temperature of dimyristoylphosphatidyl
choline (DMPC) liposomes induced by partitioning of the steroid into t
he lipid bilayers. The residual poly(vinyl alcohol) used as an emulsif
ier in the production of the microspheres was <7% (w/w). The in vitro
deposition of the microspheres (1.00 +/- 0.21 mu m) containing BDP fro
m a Spinhaler(R) to a cascade impactor at a flow rate of 60 l/min, res
ulted in 20% of the emitted dose deposited on stages corresponding to
particles <3 mu m and approximately 42% <5 mu m. (C) 1998 Elsevier Sci
ence B.V. All rights reserved.